V Paradis
Overview
Explore the profile of V Paradis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
1484
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Castera L, Winnock M, Pambrun E, Paradis V, Perez P, Loko M, et al.
HIV Med
. 2013 Sep;
15(1):30-9.
PMID: 24007567
Objectives: Combining noninvasive tests increases diagnostic accuracy for staging liver fibrosis in hepatitis C virus (HCV)-infected patients, but this strategy remains to be validated in HIV/HCV coinfection. We compared the...
12.
Pupulim L, Vullierme M, Paradis V, Valla D, Terraz S, Vilgrain V
Clin Radiol
. 2013 Mar;
68(7):e362-9.
PMID: 23537576
Aim: To evaluate the diagnosis and presentation of liver tumours in patients with congenital portosystemic shunts (CPS). Materials And Methods: Eight patients were diagnosed in Hôpital Beaujon as having CPS....
13.
Cauchy F, Zalinski S, Dokmak S, Fuks D, Farges O, Castera L, et al.
Br J Surg
. 2012 Nov;
100(1):113-21.
PMID: 23147992
Background: The incidence of metabolic syndrome-associated hepatocellular carcinoma (MS-HCC) is increasing. However, the results following liver resection in this context have not been described in detail. Methods: Data for all...
14.
Claperon A, Guedj N, Mergey M, Vignjevic D, Desbois-Mouthon C, Boissan M, et al.
Oncogene
. 2011 Aug;
31(11):1376-88.
PMID: 21822312
Scaffold proteins form multiprotein complexes that are central to the regulation of intracellular signaling. The scaffold protein ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) is highly expressed at the plasma membrane of normal...
15.
Vullierme M, Paradis V, Chirica M, Castaing D, Belghiti J, Soubrane O, et al.
J Visc Surg
. 2010 Jul;
147(1):e1-12.
PMID: 20595072
The increasing incidence of hepatocellular carcinoma (HCC) has led several countries to standardize and update its management. This review aims at summarizing these evolutions through six questions focusing on diagnosis...
16.
Vilgrain V, Paradis V
Gastroenterol Clin Biol
. 2010 Mar;
34(3):181-90.
PMID: 20202773
No abstract available.
17.
Malouf G, Dreyer C, Guedj N, Paradis V, Degos F, Belghiti J, et al.
Bull Cancer
. 2009 Apr;
96(4):405-15.
PMID: 19357015
Cholangiocarcinoma represents the second most common primary hepatobiliary cancer. Although few patients are candidates for surgery, surgical resection represents the only potential curative option. The prognosis for patients remains poor,...
18.
Paradis V, Bedossa P
Diabetes Metab
. 2009 Feb;
34(6 Pt 2):638-42.
PMID: 19195624
In patients with diabetes and metabolic syndrome, liver changes may be observed on histology that are characterized as non-alcoholic fatty liver disease (NAFLD). The NAFLD spectrum covers a variety of...
19.
Teissier J, Regimbeau J, Sommacale D, Paradis V, Sauvanet A, Belghiti J
J Chir (Paris)
. 2008 Dec;
145(5):490-2.
PMID: 19106874
It is rare for portal vein thrombosis to complicate colorectal liver metastases. However malignant portal vein thrombosis must be anticipated when considering hepatic resection. While this finding may influence long-term...
20.
Trak-Smayra V, Dargere D, Noun R, Albuquerque M, Yaghi C, Gannage-Yared M, et al.
Gut
. 2008 Apr;
58(6):825-32.
PMID: 18403495
Objective: Chronic liver diseases, including cirrhosis, may develop in obese patients. Steatosis and non-alcoholic steatohepatitis (NASH) are risk factors for progression to fibrosis. To date, diagnosis of steatosis and NASH...